Effect of atorvastatin combined with metformin on the lipid metabolism, hyperinsulinemia and oxidative stress in patients with nonalcoholic fatty liver disease

Effect of atorvastatin combined with metformin on the lipid metabolism, hyperinsulinemia and oxidative stress in patients with nonalcoholic fatty liver disease

Objective: To study the effect of atorvastatin combined with metformin on the lipid metabolism, hyperinsulinemia and oxidative stress in patients with nonalcoholic fatty liver disease (NAFLD). Methods: 56 patients with NAFLD who were treated in our hospital between June 2012 and February 2016 wer...

Full description

Bibliographic Details
Main Authors:	Jie Zhang1, Lu Wang1, Bo Wu2, Ning Gao3, Ni Kang4
Format:	Article
Language:	English
Published:	Editorial Board of Journal of Hainan Medical University 2017-05-01
Series:	Journal of Hainan Medical University
Subjects:	Non-alcoholic fatty liver disease Atorvastatin Metformin Lipid metabolism Oxidative stress
Online Access:	http://www.hnykdxxb.com/PDF/201709/15.pdf

Similar Items

Efficacy of Metformin and Atorvastatin in Correction of Indices of Carbohydrate and Lipid Metabolism in Patients with Type 2 Diabetes Mellitus
by: V.I. Pankiv
Published: (2013-03-01)

Pharmacokinetics of fixed-dose combination of atorvastatin and metformin compared with individual tablets
by: Ghim JL, et al.
Published: (2019-05-01)

Comparison of the Neuroprotective Effects of Aspirin, Atorvastatin, Captopril and Metformin in Diabetes Mellitus
by: Maryam Paseban, et al.
Published: (2019-03-01)

Pharmacokinetic Interaction between Sorafenib and Atorvastatin, and Sorafenib and Metformin in Rats
by: Agnieszka Karbownik, et al.
Published: (2020-06-01)

Assessment of the Effect of HMGCR Variant Alleles on Response to Atorvastatin Treatment in Type 2 Diabetic Egyptian Patients
by: Sara Bakr Abd El-Kader1, et al.
Published: (2019-02-01)

Systematic review of metformin versus vitamin E in treatment of nonalcoholic fatty liver disease
by: LUO Jingyi
Published: (2014-12-01)

Combined Administration of Metformin and Atorvastatin Attenuates Diabetic Cardiomyopathy by Inhibiting Inflammation, Apoptosis, and Oxidative Stress in Type 2 Diabetic Mice
by: Weikun Jia, et al.
Published: (2021-02-01)

Long-term treatment with metformin in the prevention of fatty liver in Zucker diabetic fatty rats
by: Yi Sui, et al.
Published: (2019-11-01)

Effect of doubling-dose atorvastatin intervention on lipid metabolism, insulin resistance and carotid atherosclerosis in patients with type 2 diabetes mellitus
by: Kai-Yan Ma1, et al.
Published: (2017-05-01)

Therapeutic efficacy of atorvastatin in treatment of non-alcoholic fatty liver disease in patients with type Ⅱ diabetes mellitus
by: FENG Mengdie
Published: (2013-07-01)

Metformin-Induced Changes of the Coding Transcriptome and Non-Coding RNAs in the Livers of Non-Alcoholic Fatty Liver Disease Mice
by: Jun Guo, et al.
Published: (2018-02-01)

Actions of metformin and statins on lipid and glucose metabolism and possible benefit of combination therapy
by: Mariël F. van Stee, et al.
Published: (2018-06-01)

A Comparison of the Therapeutic Effects of Metformin, Pioglitazone and Vitamin E in Patients with Non-Alcoholic Fatty Liver
by: K Shahebrahimi, et al.
Published: (2017-09-01)

Effect of Atorvastatin in Lipid Profile Changes and Inflammation Marker TNF-alpha on Diabetes Patient with Dyslipidemia
by: Wulan Panduwi Melasari, et al.
Published: (2021-04-01)

Effect of Combination Therapy with Atorvastatin and Ursodeoxycholic Acid on the Course of Ischemic Heart Disease with Co-Existent Non-Alcoholic Fatty Liver Disease and Obesity
by: Nataliya Karpyshyn
Published: (2016-12-01)

Omega-3 Fatty Acid Based Nanolipid Formulation of Atorvastatin for Treating Hyperlipidemia
by: Revathy Sreedhar, et al.
Published: (2019-06-01)

How to avoid statin hepatotoxicity in patients with obesity and liver disease? Focus on the combination of ursodeoxycholic acid and atorvastatin
by: O. N. Korneeva, et al.
Published: (2012-12-01)

The Eeffect of Metformin Combined with Calcium-Vitamin D3 Against Diet-Induced Nonalcoholic Fatty Liver Disease
by: Sara Shojaei Zarghani, et al.
Published: (2018-03-01)

Pharmacokinetic Interaction of Green Rooibos Extract With Atorvastatin and Metformin in Rats
by: Oelfah Patel, et al.
Published: (2019-10-01)

A comparison of the effectiveness of rosuvastatin, atorvastatin and simvastatin in achieving target lipid levels (according to the PROFILE-I registry)
by: Oleg V Gaisenok
Published: (2017-12-01)

The combination of atorvastatin and ethanol is not more hepatotoxic to rats than the administration of each drug alone
by: D.T. Ito, et al.
Published: (2007-03-01)

Homeostasis of Glucose and Lipid in Non-Alcoholic Fatty Liver Disease
by: Hsu-Wen Chao, et al.
Published: (2019-01-01)

Comparison the Effect of Niacin Treatment with and without Atorvastatin on Lipid Profile in Type 2 Diabetic Patients
by: Mohammad Afkhami-Ardekani, et al.
Published: (2020-09-01)

Interaction between autophagy and lipid metabolism in cell models of nonalcoholic fatty liver disease
by: YAN Rong
Published: (2017-10-01)

Atorvastatin-loaded nanostructured lipid carriers (NLCs): strategy to overcome oral delivery drawbacks
by: Mohammed Elmowafy, et al.
Published: (2017-01-01)

Effect of Vitamin E and Metformin on Fatty Liver Disease in Obese Children- Randomized Clinical Trial.
by: Kobra Shiasi Arani, et al.
Published: (2014-10-01)

Dose-dependent effects of atorvastatin in the hospitalisation period of myocardial infarction
by: O. L. Barbarash, et al.
Published: (2013-06-01)

Nonalcoholic fatty liver disease in patients with type 2 diabetes
by: N. A. Petunina, et al.
Published: (2016-12-01)

Atorvastatin and carnitine combination versus atorvastatin alone impacts on the lipid profile of haemodialyzed patients: A randomised clinical trial
by: Hamid Noshad, et al.
Published: (2018-12-01)

OBESITY AS A RISK FACTOR FOR NON-ALCOHOLIC FATTY LIVER DISEASE
by: O. A. Pavlenko
Published: (2016-02-01)

Effects of atorvastatin and metformin on development of pentylenetetrazole-induced seizure in mice
by: Mohammad Ali Zeyghami, et al.
Published: (2020-04-01)

A comparative study of atorvastatin and rosuvastatin on lipid lowering efficacy in hyperlipidemic patients
by: Samia Haque Tonu, et al.
Published: (2018-03-01)

Atorvastatin and Vitamin E Accelerates NASH Resolution by Dietary Intervention in a Preclinical Guinea Pig Model
by: Julie Hviid Klaebel, et al.
Published: (2019-11-01)

Lipid-lowering effectiveness of a Russian generic of atorvastatin in patients with various hyperlipidaemia phenotypes
by: P. P. Malyshev, et al.
Published: (2009-12-01)

Effects of Metformin Combined with Lactoferrin on Lipid Accumulation and Metabolism in Mice Fed with High-Fat Diet
by: Qing-Qing Min, et al.
Published: (2018-11-01)

The effect of moderate alcohol drinking in nonalcoholic fatty liver disease
by: Jong Hwa Choi, et al.
Published: (2020-10-01)

Metformin Alleviates Hepatic Steatosis and Insulin Resistance in a Mouse Model of High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease by Promoting Transcription Factor EB-Dependent Autophagy
by: Dan Zhang, et al.
Published: (2021-07-01)

Impact of the Gut Microbiota on Atorvastatin Mediated Effects on Blood Lipids
by: Friederike Zimmermann, et al.
Published: (2020-05-01)

Use of Atorvastatin in Lipid Disorders and Cardiovascular Disease in Chinese Patients
by: Yi-Cong Ye, et al.
Published: (2015-01-01)

Effect of atorvastatin calcium on the carotid atherosclerotic plaque and cerebral blood flow indicators in patients with TIA
by: Jing Gao, et al.
Published: (2017-01-01)

Cannot write session to /tmp/vufind_sessions/sess_g25q14s7if98nv22qdop3ub19j